R. Benjamin Free - Concepedia

Author

R. Benjamin Free

Also Known As

Jain, P., R Benjamin Free, R Free, R. B. Free, R. BENJAMIN FREE, R. Benjamin Free, R. Free, R.B. Free, R.Benjamin Free, RB Free

160

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

National Institutes of Health National Institute of Neurological Disorders and Stroke National Institute on Drug Abuse The Ohio State University Johns Hopkins University

About

R. Benjamin Free is an author at National Institutes of Health specializing in medicine, pharmacology, and molecular pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	508
2	Biochemistry	6	6	253
3	Natural Sciences	4	4	146
4	Cell Biology	3	3	182
5	Social Sciences	1	1	65

R. Benjamin Free

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Identifying Novel Protein‐Protein Interactions Using Co‐Immunoprecipitation and Mass Spectroscopy R. Benjamin Free, Lisa A. Hazelwood, David R. Sibley Current Protocols in Neuroscience	2009	95
New roles for dopamine D2 and D3 receptors in pancreatic beta cell insulin secretion Zachary J. Farino, Travis J. Morgenstern, Antonella Maffei, Molecular Psychiatry D3 ReceptorsInsulin ManagementPhysiologyDiabetesNew Roles	2019	88
Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors Despoina Aslanoglou, Suzanne Bertera, Marta Sánchez‐Soto, Translational Psychiatry	2021	86
D1 and D2 Dopamine Receptor Expression Is Regulated by Direct Interaction with the Chaperone Protein Calnexin R. Benjamin Free, Lisa A. Hazelwood, David Cabrera, Journal of Biological Chemistry Cellular PhysiologyMolecular PharmacologyCell SurfaceCell SignalingMolecular Physiology	2007	83
Discovery and Characterization of a G Protein–Biased Agonist That Inhibits β-Arrestin Recruitment to the D2 Dopamine Receptor R. Benjamin Free, Lani S. Chun, Amy E. Moritz, Molecular Pharmacology	2014	83
D1-D2 Dopamine Receptor Synergy Promotes Calcium Signaling via Multiple Mechanisms Lani S. Chun, R. Benjamin Free, Trevor Doyle, Molecular Pharmacology	2013	80
Identification of G Protein-Biased Agonists That Fail To Recruit β-Arrestin or Promote Internalization of the D1 Dopamine Receptor Jennie Conroy, R. Benjamin Free, David R. Sibley ACS Chemical Neuroscience D1r InternalizationPsychotropic MedicationPsychopharmacologyPharmacotherapyD1 Dopamine Receptor	2015	65
Reciprocal Modulation of Function between the D1 and D2 Dopamine Receptors and the Na+,K+-ATPase Lisa A. Hazelwood, R. Benjamin Free, David Cabrera, Journal of Biological Chemistry	2008	52
Synthesis and Pharmacological Characterization of Novel <i>trans</i>-Cyclopropylmethyl-Linked Bivalent Ligands That Exhibit Selectivity and Allosteric Pharmacology at the Dopamine D<sub>3</sub> Receptor (D<sub>3</sub>R) Vivek Kumar, Amy E. Moritz, Thomas M. Keck, Journal of Medicinal Chemistry	2017	47
Ring E analogs of methyllycaconitine (MLA) as novel nicotinic antagonists Stephen C. Bergmeier, David J. Lapinsky, R. Benjamin Free, Bioorganic & Medicinal Chemistry Letters BiochemistryMedicineNatural SciencesNicotineMechanism Of Action	1999	45

Page 1